651 Stock Chart & Stats
€0.01
>-€0.01(-1.25%)
At close: 4:00 PM EST
€0.01
>-€0.01(-1.25%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)2.00K
Market Cap
€3.09M
Enterprise Value€22.87
Total Cash (Recent Filing)€25.64M
Total Debt (Recent Filing)€12.31M
Price to Earnings (P/E)―
Beta11.97
Next Earnings
Oct 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding1,025,575,800
10 Day Avg. Volume0
30 Day Avg. Volume2,000
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€12.49M
Bulls Say, Bears Say
Bulls Say
Partial Balance-sheet RepairThe balance sheet has shown tangible improvement versus the most stressed periods: equity rebuilt to a higher level and total debt is lower than in 2024–2025. That repair improves financing flexibility and reduces near-term solvency risk, supporting survival while turnaround actions proceed.
Improving Cash Burn TrendOperating and free cash flow remain negative, but the trailing-twelve-month cash burn has improved versus 2024–2025. A sustained reduction in cash outflows indicates progress on cost control or revenue stabilization, which is durable if management preserves that discipline and reduces reliance on external funding.
Exposure To Structural Infection-control DemandLifeClean serves infection-control and hygiene end markets—healthcare and public settings—which represent enduring demand for disinfectants and cleaning solutions. Structural regulatory and institutional hygiene standards support recurring procurement, offering a persistent addressable market for the company’s products.
Bears Say
Persistent UnprofitabilityThe company reports negative operating and net margins in every period and gross profit deteriorated sharply on a TTM basis. Persistent losses undermine retained earnings and limit reinvestment capacity, making sustainable profitability a material structural challenge absent clear margin recovery.
Shrinking Revenue TrendRevenue is contracting—TTM declines of roughly 12.5%—which implies weakening demand or pricing pressure for core disinfectant products. A sustained top-line decline reduces operating leverage, makes fixed-cost coverage harder, and lengthens the runway needed to restore sustainable margins.
Consistent Negative Cash GenerationOperating and free cash flow remain negative across all reported periods, and free cash flow roughly tracks net loss. Ongoing cash consumption forces reliance on external funding or balance-sheet maneuvers, constraining strategic options and raising refinancing and dilution risk over the medium term.
LifeClean International AB News
651 FAQ
What was LifeClean International AB’s price range in the past 12 months?
LifeClean International AB lowest stock price was <€0.01 and its highest was €0.07 in the past 12 months.
What is LifeClean International AB’s market cap?
LifeClean International AB’s market cap is €3.09M.
When is LifeClean International AB’s upcoming earnings report date?
LifeClean International AB’s upcoming earnings report date is Oct 23, 2026 which is in 77 days.
How were LifeClean International AB’s earnings last quarter?
LifeClean International AB released its earnings results on Jul 09, 2026. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
Is LifeClean International AB overvalued?
According to Wall Street analysts LifeClean International AB’s price is currently Overvalued.
Does LifeClean International AB pay dividends?
LifeClean International AB does not currently pay dividends.
What is LifeClean International AB’s EPS estimate?
LifeClean International AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeClean International AB have?
LifeClean International AB has 1,025,575,800 shares outstanding.
What happened to LifeClean International AB’s price movement after its last earnings report?
LifeClean International AB reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LifeClean International AB?
Currently, no hedge funds are holding shares in DE:651
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LifeClean International AB
LifeClean International AB (publ) is a Swedish company that engages in the comprehensive process of investigating, manufacturing, promoting, and distributing disinfection agents within Sweden. A key innovation from the company is its patented surface disinfectant. This powerful formula is engineered to eradicate a wide array of harmful microorganisms, including spores, fungi, tenacious biofilms, bacteria, and viruses. It is designed for versatile application across various equipment and surfaces, encompassing flooring, walls, furniture, and overhead structures. The enterprise was founded in 2012 and maintains its operational base in Uddevalla, Sweden.